FBO#6111
A - Research and Development
FEDBIZOPPS: AWARDS - August 17, 2018
- N00014-18-C-2035 - $5,163,704.00
DANIEL H. WAGNER ASSOCIATES, INC.
DANIEL H. WAGNER ASSOCIATES, INCORPORATED<br />559 WEST UWCHLAN AVENUE, Suite 140<br />SUITE 140<br />EXTON<br />PA<br />19341<br />USA
- HR001118C0129 - $480,439
STRATEGIC TECHNOLOGIES
Viasat, Inc., 6155 El Camino Real, Carlsbad, California 92009-1602, United States
- HHSN272201800040C - $591,870
OPTIMIZED DRY POWDER FORMULATION AND DELIVERY FOR INHALED CLOFAZIMINE
Creare, LLC, 16 Great Hollow Road<br />, Hanover, New Hampshire 03755, United States
- HHSN272201800041C - $520,304
DEVELOPMENT OF A CLOFAZIMINE AEROSOL FORMULATION FOR THE TREATMENT OF TUBERCULOSIS
QrumPharma, Inc., 215 Decatur St., Doylestown, Pennsylvania 18901, United States
- HHSN272201800039C - $3,599,145
INHALED DELIVERY OF CLOFAZIMINE - A HIGH EFFICIENCY, FLOW INDEPENDENT, TARGETED, LOW COST DPI
Via Therapeutics, LLC, 11113 Alison Parke Trail, Austin, Texas 78750, United States
| This Issue's Index | Today's FBO Daily Index Page |
Created on 15-Aug-2018 by Loren Data Corp. -- info@fbodaily.com